Saturday, December 27, 2014

Best Managed Healthcare Stocks For 2014

Two groups affiliated with independent broker-dealer Securities America shared news Monday on how they expect to recruit both more hybrid advisors and wirehouse reps to their platforms.

Arbor Point Advisors — formed by Securities America and NorthStar Financial Services Group as a joint venture in July to support hybrid advisory firms — has hired Jeffrey Schmaltz as a regional sales director in Fort Worth, Texas.

“When hiring a business development professional, we strive to find someone who already understands the complexities associated with the independent advisory model,” said Curtis Reed, president of Arbor Point Advisors, in a press release. "Jeff’s years of experience working with large, complex advisory firms, and being an advisor himself, make him the perfect addition to our team. His leadership and insight into the ever-changing investment advisory landscape has helped hundreds of firms grow, compete and succeed.”

Schmaltz began work in the financial services industry in 1986 as a Fidelity Investments representative in Dallas. He was with Bear Stearns from 1989 to 1995, when he returned to Fidelity Investments. He joined the institutional division of Fidelity in 2001 and became responsible for developing new business relationships with advisors in transition, RIAs, family offices, broker-dealers, financial planners and consulting firms.

Hot Value Companies To Invest In 2015: MagnaChip Semiconductor Corporation (MX)

MagnaChip Semiconductor Corporation designs and manufactures analog and mixed-signal semiconductor products for high-volume consumer applications. It operates in three segments: Display Solutions, Power Solutions, and Semiconductor Manufacturing Services. The Display Solutions segment offers source and gate drivers, and timing controllers that cover a range of flat panel displays used in liquid crystal displays (LCDs), light emitting diodes (LEDs), 3D and organic light emitting diode televisions and displays, notebooks, and mobile communications and entertainment devices. The Power Solutions segment develop, manufactures, and markets power management solutions, including metal oxide semiconductor field effect transistors, power modules, analog switches, LED drivers, DC-DC converters, voice coil motor drivers, and linear regulators. This segment offers its products for a range of devices, including LCD, LED, 3D televisions, smartphones, mobile phones, desktop PCs, notebooks , tablet PCs, and other consumer electronics, as well as for industrial applications, such as power suppliers, LED lighting, and home appliances. The Semiconductor Manufacturing Services segment manufactures various products comprising display drivers, LED drivers, audio encoding and decoding devices, microcontrollers, touch screen controllers, RF switches, park distance control sensors for automotives, electronic tag memories, and power management semiconductors. This segment offers semiconductor manufacturing services to fabless analog and mixed-signal semiconductor companies. MagnaChip Semiconductor Corporation provides its products and services to consumer electronics OEMs, subsystem designers, and contract manufacturers through a direct sales force, as well as through a network of authorized agents and distributors in the United States, Korea, Taiwan, China, Japan, Hong Kong, and Macau. The company is headquartered in Seoul, South Korea.

Advisors' Opinion:
  • [By Wallace Witkowski]

    Shares of MagnaChip Semiconductor Corp. (MX) �fell 13% to $12.50 on moderate volume after the company said it incorrectly stated revenue and has to restate its financial statements going back to 2011. Also, the company withdrew its guidance for the fourth quarter.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, consumer gadget chip maker MagnaChip Semiconductor (NYSE: MX  ) has earned a coveted five-star ranking.

Best Managed Healthcare Stocks For 2014: BGC Partners Inc.(BGCP)

BGC Partners, Inc. operates as a financial intermediary to the financial markets specializing in the brokering of various financial products. It provides electronic marketplaces, including government bond markets, spot foreign exchange, foreign exchange options, corporate bonds, and credit default swaps in various financial markets through its eSpeed- and BGC Trader- branded trading platform which can be accessed through its high speed data network, over the Internet, or third party communication networks. The company?s brokerage services include trade execution, broker-dealer services, clearing, processing, information, and other back office services, as well as cover various products, including fixed income securities, interest rate swaps, foreign exchange, equities, equity derivatives, credit derivatives, commodities, futures, and structured products. It also provides financial technology solutions, market data, and analytics related to financial instruments and markets . In addition, the company offers customized screen-based market solutions, which enables its clients to develop a marketplace, trade with their customers, issue debt, trade odd lots, access program trading interfaces, and access its network and intellectual property. Further, it licenses intellectual property portfolio and software solutions to various financial markets participants; and provides software development, software maintenance, customer support, infrastructure, and internal technology services to support electronic trading platforms. The company serves banks, broker-dealers, investment banks, trading firms, hedge funds, governments, investment firms, professional trading firms, futures commission merchants, and other professional market participants and financial institutions in the United States, the United Kingdom, France, Asia, Europe, Africa, the Middle East, and other Americas. The company was founded in 1999 and is based in New York, New York.

Advisors' Opinion:
  • [By Selena Maranjian]

    Finally, Tudor Investment's biggest closed positions included Apple�and the iShares MSCI Emerging Market Index Fund ETF. Other closed positions of interest include Frontier Communications (NASDAQ: FTR  ) and BGC Partners (NASDAQ: BGCP  ) . Frontier, recently yielding more than 9%, is a rural telecom specialist. It's weighed down with considerable debt, and is shifting its business focus, favoring business customers more. It's been posting declining revenue lately, though, and its credit rating took a hit in recent months, also. Some worry that its acquisition of landline business from Verizon�may not be as lucrative as expected, and fear a dividend cut.

  • [By Eric Volkman]

    BGC Partners (NASDAQ: BGCP  ) is waxing optimistic about its current quarter. The company updated its previously issued guidance, indicating that its nearly complete Q2 will come in at the higher end of the range for revenues and EPS. The former was for distributable earnings revenue of $435 million-$465 million, while the latter anticipated pre-tax distributable earnings of $42 million-$53 million.

  • [By Brian Womack]

    ��t�� a defensive strategy because R&D costs are going up and the number of customers is going down,��said Amir Anvarzadeh, a manager of Japanese equity sales at BGC Partners Inc. (BGCP) in Singapore. ��his tells you there�� a problem in the industry.��

Best Managed Healthcare Stocks For 2014: Cardiovascular Systems Inc.(CSII)

Cardiovascular Systems, Inc., a medical device company, focuses on developing and commercializing minimally invasive treatment solutions for vascular disease. Its primary products include catheter-based platforms, such as the Diamondback 360�PAD System, the Diamondback Predator 360�PAD System, and Stealth 360�PAD System that are used for the treatment of a range of plaque types in leg arteries above and below the knee. The PAD Systems consists of a single-use catheter that travels over its proprietary ViperWire guidewire and are used in conjunction with a reusable external control unit or a saline infusion pump. It markets and sells its products through direct sales force to hospitals and office based laboratories in the United States. The company was founded in 1989 and is headquartered in St. Paul, Minnesota.

Advisors' Opinion:
  • [By Todd Campbell]

    So far I've outlined the reasons for the robust returns last year at diabetes device maker Dexcom and cardiovascular device play Cardiovascular Systems (NASDAQ: CSII  ) . That brings us to No. 3 in my series,�Abiomed (NASDAQ: ABMD  ) , a company that saw its latest product line propel its shares 98% higher in 2013.

  • [By Brian Pacampara]

    Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, medical device company Cardiovascular Systems (NASDAQ: CSII  ) has received a distressing two-star ranking.

Best Managed Healthcare Stocks For 2014: Acura Pharmaceuticals Inc.(ACUR)

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, and decongestants. The company offers OXECTA Tablets CII, which are oral formulations of oxycodone HCl for the management of acute and chronic moderate to severe pain; and Impede PSE, a pseudoephedrine hydrochloride tablet product candidate. It is also developing opioid analgesic product candidates, which would be used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. In addition, the company investigates and develops mechanisms to incorporate abuse deterrent features into abused and misused pharmaceutical products using its Impede Technology. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize certain opioid analgesic products utilizing the company?s proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.

Advisors' Opinion:
  • [By John Udovich]

    On Tuesday, small cap specialty pharmaceutical company�Acura Pharmaceuticals, Inc (NASDAQ: ACUR) surged 27.52% to $1.90 on no apparent news beyond a speculative Seeking Alpha article that talked about certain catalysts����meaning its worth taking a closer look at the company to see what�� going on and whether shares could move higher.�

  • [By Sean Williams]

    ALKS-7106 for the treatment of pain has big potential as it encompasses a broad audience, but it'll need to overcome the common stigma of pain drugs with regard to easy abuse potential. According to the press release, Alkermes will be introducing newer technology that will make its opioid-based drug more resistant to abuse. It should be curious to see how well this performs as there aren't many successful abuse-resistant drugs, or companies developing those drugs for that matter. Acura Pharmaceuticals (NASDAQ: ACUR  ) , for instance, successfully brought moderate-to-severe painkiller Oxecta to market in 2011 (which it subsequently licensed to Pfizer) and a bioequivalent version of decongestant pseudoephedrine to market last year, but sales of neither drug has exactly taken off. Like with its MMF prodrug, Alkermes anticipates a mid-2014 clinical trial launch date.

  • [By Rick Munarriz]

    Thursday
    Acura Pharmaceuticas (NASDAQ: ACUR  ) checks in on Thursday. Drugmakers use Acura's Aversion and Impede technologies to create abuse-deterrent treatments. In short, if an abuser tries to extract the active ingredient of a drug to heighten addictive experiences, Acura's technologies kick in to make the whole dose unusable.

Best Managed Healthcare Stocks For 2014: Essar Energy Plc (ESSR)

Essar Energy plc is a holding company. The Company is an energy company with assets across the power and oil and gas industries. The Company operates in the areas petroleum refining and marketing, exploration and production and power transmission and generation. The Refining and Marketing business in India comprises of the Vadinar refinery located on the west coast of India and a retail franchise network of around 1,400 fuel stations across India and the Refining, and Marketing business in the United Kingdom comprises of the Stanlow refinery located near Liverpool, north west England and on the south bank of Manchester ship canal. The Company�� exploration and production segment includes a portfolio of 15 blocks and fields in the various stages of exploration and production of oil and gas in India, Indonesia, Nigeria and Vietnam. In Power segment, the Company operates coal fired, captive fuel and gas based power plants in India and Canada together with a number of mining assets. Advisors' Opinion:
  • [By Sarah Jones]

    Essar Energy Plc (ESSR) climbed 2.5 percent to 122 pence after reporting that revenue rose 24 percent to $27.3 billion in the 12 months through March. The company cited higher margins and volumes at its Vadinar refinery in India and its Stanlow refinery in the U.K.

Best Managed Healthcare Stocks For 2014: Columbia Sportswear Company(COLM)

Columbia Sportswear Company, together with its subsidiaries, engages in the design, development, sourcing, marketing, and distribution of outdoor apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada. It provides apparel, accessories, and equipment for men, women, and youth under Columbia and Mountain Hardwear brands used during outdoor activities, such as skiing, snowboarding, hiking, climbing, mountaineering, camping, hunting, fishing, trail running, water sports, and adventure travel. The company also offers footwear products, including lightweight hiking boots, trail running shoes, rugged cold weather boots, sandals, and casual shoes for men and women under Columbia, Sorel, and Montrail brands, as well as for youth under the Columbia and Sorel brands. Columbia Sportswear Company sells its products through wholesale distribution channels, independent distributors, direct-to-consum er channels, and licensees, as well as online to independent distributors and consumers. As of December 31, 2011, it operated 43 outlet retail stores and 8 branded retail stores in the United States; 7 outlet retail stores and 3 branded retail stores in various locations in western Europe; and 2 outlet retail stores in Canada, as well as 111 and 236 dealer-operated, branded, outlet, and shop-in-shop locations in Japan and Korea. Columbia Sportswear Company was founded in 1938 and is headquartered in Portland, Oregon.

Advisors' Opinion:
  • [By Roberto Pedone]

    Columbia Sportswear (COLM) is engaged in the design, develop, market and distribute active outdoor apparel, footwear, accessories and equipment under four brands namely Columbia, Mountain Hardwear, Sorel and Montrail. This stock closed up 1% to $65.29 in Monday's trading session.

    Monday's Volume: 126,000

    Three-Month Average Volume: 75,362

    Volume % Change: 50%

    From a technical perspective, COLM trended modestly higher here right above its 50-day moving average of $62.08 with above-average volume. This stock has been uptrending strong for the last five months, with shares pushing higher from its low of $54.66 to its recent high of $66.69. During that move, shares of COLM have been consistently making higher lows and higher highs, which is bullish technical price action. That move is now pushing shares of COLM within range of triggering a major breakout trade. That trade will hit if COLM manages to take out some key near-term overhead resistance levels at $65.90 to its 52-week high at $66.69 with high volume.

    Traders should now look for long-biased trades in COLM as long as it's trending above its 50-day at $62.08 or above more support at $61.75 and then once it sustains a move or close above those breakout levels with volume that hits near or above 75,362 shares. If that breakout triggers soon, then COLM will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $70 to $75.

  • [By Anh HOANG]

    Another peer, Columbia Sportswear Company (NASDAQ: COLM  ) has also spent a lot of money on a major marketing campaign for its Omni-Freeze ZERO fabric. This fabric uses the industry's leading cooling technology and provides prolonged cooling for its users. This could be considered an important new franchise to complement the existing franchise innovations portfolio of Columbia Sportswear. Its fall 2014 product lines have been structured so that they were more reasonably priced to drive sales growth for the company.

  • [By John Kell]

    Columbia Sportswear Co.'s(COLM) fourth-quarter profit slipped 7% as an asset impairment charge weighed on the active outdoor apparel maker’s bottom line, masking a rise in revenue. Shares rose 6.4% to $83.70 premarket.

  • [By Grace L. Williams]

    With recent M&A in the yoga and athletic-wear space (such as Prana�� acquisition by Columbia (COLM) and Lorna Jane now up for sale as per recent media reports), Lululemon’s geographical diversification efforts are timely given that the domestic competitive environment is certainly showing no signs of abating.

No comments:

Post a Comment